Syros Pharmaceuticals Inc logo

Syros Pharmaceuticals Inc Share Price Today (NASDAQ: SYRS)

Syros Pharmaceuticals Inc share price is $0 & ₹0.00 as on 19 Mar 2025 IST

▲

-0.1

(-100%)

Market is closed - opens 7 PM, 07 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 20 Mar 2025

View live Syros Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Syros Pharmaceuticals Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Syros Pharmaceuticals Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Syros Pharmaceuticals Inc (SYRS) Key Statistics

in dollars & INR

Previous Close
$0.105
Open
$0.0686
Market Capitalization
$3.1M
Today's Volume
$2.9M
Revenue TTM
$386.0K
EBITDA
$-110.2M
Earnings Per Share (EPS)
$-3.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-776.96%

How to invest in Syros Pharmaceuticals Inc Stock (SYRS) from India?

It is very easy for Indian residents to invest directly in Syros Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Syros Pharmaceuticals Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Syros Pharmaceuticals Inc or SYRS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Syros Pharmaceuticals Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Syros Pharmaceuticals Inc shares which would translate to null fractional shares of Syros Pharmaceuticals Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Syros Pharmaceuticals Inc, in just a few clicks!

Global Institutional Holdings in Syros Pharmaceuticals Inc

  • Bain Capital Life Sciences Investors, LLC

    10.25%

  • BlackRock Inc

    1.03%

  • Vanguard Group Inc

    1.00%

  • Omega Fund Management LLC

    0.94%

  • Geode Capital Management, LLC

    0.73%

  • Affinity Asset Advisors, LLC

    0.56%

Analyst Recommendation on Syros Pharmaceuticals Inc

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Syros Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

About Syros Pharmaceuticals Inc

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome and Phase II clinical trial for patients with acute myeloid leukemia; SY-2101, a novel oral form of arsenic trioxide for treating patients with acute promyelocytic leukemia; and SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
Organization
Syros Pharmaceuticals Inc
Employees
68
CEO
Dr. James E. Bradner M.D.
Industry
Health Technology

Management People of Syros Pharmaceuticals Inc

NameTitle
Dr. James E. Bradner M.D.
Founder
Dr. Nathanael S. Gray Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Matthew Foster
Chief Restructuring Officer

Important FAQs about investing in SYRS Stock from India :

Can Indians buy Syros Pharmaceuticals Inc shares?

Yes, Indians can invest in the Syros Pharmaceuticals Inc (SYRS) from India.

With INDmoney, you can buy Syros Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Syros Pharmaceuticals Inc at zero transaction cost.

How can I buy Syros Pharmaceuticals Inc shares from India?

It is very easy to buy Syros Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Syros Pharmaceuticals Inc (SYRS) be purchased?

Yes, you can buy fractional shares of Syros Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Syros Pharmaceuticals Inc stocks?

To start investing in Syros Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Syros Pharmaceuticals Inc?

Today's market capitalisation of Syros Pharmaceuticals Inc SYRS is 3.1M

Who is the Chief Executive Officer (CEO) of Syros Pharmaceuticals Inc ?

Dr. James E. Bradner M.D. is the current Chief Executive Officer (CEO) of Syros Pharmaceuticals Inc.